Trial Profile
A Phase IIa Randomized, Double-Blind, Parallel-Group, Placebo and Active-Controlled, Clinical Trial to Study the Efficacy and Safety of MK0974 Co-Administered With Ibuprofen or Acetaminophen in Patients With Migraine With or Without Aura.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 May 2022
Price :
$35
*
At a glance
- Drugs Telcagepant (Primary) ; Ibuprofen; Paracetamol
- Indications Migraine with aura; Migraine without aura
- Focus Adverse reactions; Therapeutic Use
- 30 Aug 2011 New source identified and integrated (Clinical Trials Registry - India; CTRI2009-091-000291).
- 27 Jun 2010 Results were reported at the 52nd Annual Scientific Meeting of the American Headache Society.
- 09 Oct 2009 Actual end date changed from Aug 2009 to Sep 2009 as reported by ClinicalTrials.gov.